PS.

Transitional Drugs 4

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)contractFind a Tender ↗Ref ocds-h6vhtk-054590Procurement Act 2023SME suitableactive

Estimated value

—

Awarded value

—

Suppliers

3

Lots

1

1 awarded

Published

25 Oct 2025

Description

This contract is for the provision of Transitional Drugs 4 - namely Ticagrelor and Eltrombopag

Scope

Reference
PHA FTS 59531
Commercial tool
Standalone contract
Contract dates
30 Sept 2025 to 31 Jan 2027
Possible extension to 31 Jan 2028

Potential 12 month extension available

CPV classifications
33600000
Contract locations
Wales, United Kingdom
Particular suitability
Small and medium-sized enterprises (SME)

Award criteria

Criteria the buyer will use to evaluate bids.

NameDescriptionTypeWeighting
Product Quality/AcceptabilityPass/Failquality1.00%
Financial (Overall Cost of Contract)Weighting 85cost2.00%
Environmental/social Value/Community BenefitsWeighting 15quality3.00%

Submission & procedure

Procedure
Open procedure

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

—

Award date

—

Contract start

—

Contract end

—

Awarded to
NO
Novartis
AP
Amarox Pharma
NL
Novumgen Ltd